SCHEMBL5770940

SCHEMBL5770940

Cc1cc(CC(NC(=O)OC(=O)NC(c2ncc[nH]2)C(c2cc(C)c3nn(COCC[Si](C)(C)C)cc3c2)C(C)(C)C)c2nccn2-c2ccccc2[N+](=O)[O-])cc2cn(COCC[Si](C)(C)C)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13756213 0.84 CCR3 (0.33) —
SCHEMBL5765307 0.84 CALCRL (0.35) —
SCHEMBL5770935 0.83 — —
SCHEMBL4507059 0.83 CCR3 (0.35) —
SCHEMBL4507070 0.83 CCR3 (0.35) —
SCHEMBL4518156 0.78 — —
SCHEMBL13756203 0.74 AAK1 (0.34) —
SCHEMBL4507068 0.70 — —
SCHEMBL13756208 0.68 CALCRL (0.39) —
SCHEMBL13756230 0.68 CALCRL (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689738-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS Bristol-Myers Squibb Company (US) 2006-08-16 — — EP disclosed
WO-2005056550-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-23 — — WO disclosed
Send feedback